SWOG clinical trial number
SWOG-8991 (EST-3588) (RTOG-8815) (INT-0096)
A Phase III Study of Cisplatin plus Etoposide Combined with Standard Fractionation Thoracic Radiotherapy vs Cisplatin plus Etoposide Combined with Multiple Daily Fractionated Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer
Closed
Phase
Published
Abbreviated Title
A Phase III Study of Cisplatin plus Etoposide Combined with Standard Fractionation Thoracic Radiotherapy vs Cisplatin plus Etoposide Combined with Multiple Daily Fractionated Thoracic Radiotherapy…
Activated
02/15/1990
Closed
08/01/1992
Research committees
Lung Cancer
Publication Information Expand/Collapse
Other Clinical Trials
S2414
SWOG Clinical Trial Number
Research Committee(s)
Lung Cancer
Symptom Control and Quality of Life
Activated
03/14/2025
1% Accrual
Accrual
1%
Open
Phase
A082002
SWOG Clinical Trial Number
Research Committee(s)
Lung Cancer
Activated
12/21/2021
Open
Phase
CTSU/NRG-LU007
SWOG Clinical Trial Number
Research Committee(s)
Lung Cancer
Activated
08/17/2020
Open